Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors (Q34644769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Nicolas Isambert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Pierre Fumoleau

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Christophe Ferrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Sylvie Zanetta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jacques Bauer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Kevin Ragot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Gérard Lizard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jean-François Jeannin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Marc Bardou

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

2 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1186/1471-2407-13-172

27 February 2020

exact match

0 references

cites work

Toll-like receptors as targets for immune disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Lipid A-mediated tolerance and cancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

7 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Review article: immune suppression and colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Mechanisms of the antitumoral effect of lipid A.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Phase-I study of intravenous modified lipid A.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Antitumor effect of synthetic derivatives of lipid A in an experimental model of colon cancer in the rat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

International trends in colorectal cancer incidence rates

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

ADRB3 adrenergic receptor is a key regulator of human myometrial apoptosis and inflammation during chorioamnionitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-172

Deaths: leading causes for 2007.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Downregulation of the proinflammatory cytokine response to endotoxin by pretreatment with the nontoxic lipid A analog SDZ MRL 953 in cancer patients.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3626800

Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide

26 October 2018

1 reference

12 December 2020

Lipid A-induced responses in vivo

1 reference

12 December 2020

Biological activities and antitumor effects of synthetic lipid A analog linked N-acylated serine

1 reference

12 December 2020

Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-13-172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 February 2020

1048846755

0 references

Fatcat ID

release_m2hoivdgdbeq7d2wxbajnlts2e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m2hoivdgdbeq7d2wxbajnlts2e

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23547558%20AND%20SRC:MED&resulttype=core&format=json